Literature DB >> 20210548

Laboratory diagnosis of Buruli ulcer disease.

Marcus Beissner1, Karl-Heinz Herbinger, Gisela Bretzel.   

Abstract

Buruli ulcer disease (BUD), caused by Mycobacterium ulcerans, has become the third most common mycobacterial disease worldwide. Antimycobacterial therapy is considered the treatment of choice. With the introduction of antimycobacterial treatment, laboratory confirmation of clinically suspected cases became crucial for the clinical management of BUD. Currently available diagnostic laboratory tests include microscopy, culture, histopathology and IS2404 PCR. Several IS2404 PCR assays were applied for case confirmation in endemic countries, and IS2404 PCR is considered the most sensitive method for the laboratory confirmation of BUD. Due to the extended presence of mycobacterial DNA under antimycobacterial treatment, however, PCR is not suitable for monitoring of treatment success. Currently, cultures are considered the only valid confirmatory test for the detection of viable bacilli.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20210548     DOI: 10.2217/fmb.10.3

Source DB:  PubMed          Journal:  Future Microbiol        ISSN: 1746-0913            Impact factor:   3.165


  19 in total

1.  Efficiency of fine-needle aspiration compared with other sampling techniques for laboratory diagnosis of Buruli ulcer disease.

Authors:  Karl-Heinz Herbinger; Marcus Beissner; Kristina Huber; Nana-Yaa Awua-Boateng; Jörg Nitschke; William Thompson; Erasmus Klutse; Pius Agbenorku; Awovi Assiobo; Ebekalisai Piten; Franz Wiedemann; Erna Fleischmann; Kerstin Helfrich; Ohene Adjei; Thomas Löscher; Gisela Bretzel
Journal:  J Clin Microbiol       Date:  2010-08-25       Impact factor: 5.948

Review 2.  Treating Mycobacterium ulcerans disease (Buruli ulcer): from surgery to antibiotics, is the pill mightier than the knife?

Authors:  Paul J Converse; Eric L Nuermberger; Deepak V Almeida; Jacques H Grosset
Journal:  Future Microbiol       Date:  2011-10       Impact factor: 3.165

Review 3.  Buruli Ulcer, a Prototype for Ecosystem-Related Infection, Caused by Mycobacterium ulcerans.

Authors:  Dezemon Zingue; Amar Bouam; Roger B D Tian; Michel Drancourt
Journal:  Clin Microbiol Rev       Date:  2017-12-13       Impact factor: 26.132

4.  Effects of decontamination, DNA extraction, and amplification procedures on the molecular diagnosis of Mycobacterium ulcerans disease (Buruli ulcer).

Authors:  Dissou Affolabi; N'Dira Sanoussi; Koen Vandelannoote; Mathieu Odoun; Frank Faïhun; Ghislain Sopoh; Séverin Anagonou; Françoise Portaels; Miriam Eddyani
Journal:  J Clin Microbiol       Date:  2012-01-18       Impact factor: 5.948

5.  Detection of Mycobacterium ulcerans by the loop mediated isothermal amplification method.

Authors:  Anthony Ablordey; Diana Ackon Amissah; Isaac Frimpong Aboagye; Ben Hatano; Toshio Yamazaki; Tetsutaro Sata; Koichi Ishikawa; Harutaka Katano
Journal:  PLoS Negl Trop Dis       Date:  2012-04-03

6.  Laboratory confirmation of Buruli ulcer disease in Togo, 2007-2010.

Authors:  Gisela Bretzel; Kristina Lydia Huber; Basil Kobara; Marcus Beissner; Ebekalisai Piten; Karl-Heinz Herbinger; Franz Xaver Wiedemann; Komi Amekuse; Abiba Banla Kere; Kerstin Helfrich; Erna Fleischmann; Thomas Löscher; Adolf Diefenhardt; Jörg Nitschke
Journal:  PLoS Negl Trop Dis       Date:  2011-07-19

7.  Mycolactone diffuses into the peripheral blood of Buruli ulcer patients--implications for diagnosis and disease monitoring.

Authors:  Fred S Sarfo; Fabien Le Chevalier; N'Guetta Aka; Richard O Phillips; Yaw Amoako; Ivo G Boneca; Pascal Lenormand; Mireille Dosso; Mark Wansbrough-Jones; Romain Veyron-Churlet; Laure Guenin-Macé; Caroline Demangel
Journal:  PLoS Negl Trop Dis       Date:  2011-07-19

8.  Evaluation of different DNA extraction methods and loop-mediated isothermal amplification primers for the detection of Mycobacterium ulcerans in clinical specimens.

Authors:  Anthony Ablordey; Evans Ahotor; Charles A Narh; Sandra A King; Isra Cruz; Joseph M Ndung'u; Dziedzom K de Souza
Journal:  BMC Infect Dis       Date:  2021-06-23       Impact factor: 3.090

9.  Detection of viable Mycobacterium ulcerans in clinical samples by a novel combined 16S rRNA reverse transcriptase/IS2404 real-time qPCR assay.

Authors:  Marcus Beissner; Dominik Symank; Richard Odame Phillips; Yaw Ampem Amoako; Nana-Yaa Awua-Boateng; Fred Stephen Sarfo; Moritz Jansson; Kristina Lydia Huber; Karl-Heinz Herbinger; Florian Battke; Thomas Löscher; Ohene Adjei; Gisela Bretzel
Journal:  PLoS Negl Trop Dis       Date:  2012-08-28

10.  Implementation of a national reference laboratory for Buruli ulcer disease in Togo.

Authors:  Marcus Beissner; Kristina Lydia Huber; Kossi Badziklou; Wemboo Afiwa Halatoko; Issaka Maman; Felix Vogel; Bawimodom Bidjada; Koffi Somenou Awoussi; Ebekalisai Piten; Kerstin Helfrich; Carolin Mengele; Jörg Nitschke; Komi Amekuse; Franz Xaver Wiedemann; Adolf Diefenhardt; Basile Kobara; Karl-Heinz Herbinger; Abiba Banla Kere; Mireille Prince-David; Thomas Löscher; Gisela Bretzel
Journal:  PLoS Negl Trop Dis       Date:  2013-01-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.